BARDA Invests $59 Million in OPKO Health’s ModeX Therapeutics for Next-Gen Antibody Defense

Partnership
Annexus Health partners with the National Infusion Center Association
Annexus teams up with NICA to improve patient access to affordable infusion treatments, ensuring quality care for those requiring provider-administered therapies. Read More>>

Deals
OPKO Health bags BARDA contract to combat Antibody threats
OPKO Health subsidiary ModeX Therapeutics received a US$59 million contract from BARDA to develop a next-generation MSTAR multi-specific antibody targeting SARS-CoV-2 variants. Read More>>
Induction Healthcare secures US$1.7 Million in three new NHS national portal contracts
These contracts enable patients to access diagnostic details, Attend Anywhere video consultations, and maternity records, helping the company streamline healthcare delivery. Read More>>

Centre Setup and Expansion
CHRISTUS Health to open new expanded Cancer Center
CHRISTUS Health is expanding to give patients access to high-quality care in Bossier through the new, expanded location of the Cancer Center. Read More>>

Executive Movement
Recuro Health appoints SVP/Chief Product & Technology Officer
Recuro Health appoints Ash Tengshe as SVP/Chief Product & Technology Officer. He brings extensive leadership experience in healthcare tech and product development. Read More>>

Product Launch
Atropos Health launches new product to analyze Patient Populations
Atropos Health’s new tool can efficiently process large datasets, and help identify subsets of patients for specific treatments. Read More>>

Deal
Trace Medical & Outset Medical sign distribution agreement
Trace Medical has inked a long-term deal with Outset Medical for Home Medical Equipment (HME) providers to rent the Tablo® Hemodialysis System. Read More>>

Partnership
OrthoPediatrics Corp. partners with Children’s National Hospital in Washington
OrthoPediatrics Corp. and Children’s National Hospital in the “Alliance for Pediatric Device Innovation” will advise the development of medical devices designed for children. Read More>>

Centre Setup and Expansion
Bayer Opens US$250 Million Cell Therapy Manufacturing Facility in Berkeley
The site will produce materials for late-stage clinical trials and the potential commercial launch of BlueRock Therapeutics BRT-DA01 cell therapy for Parkinson’s disease. Read More>>

Merger and Acquisition
Getinge acquires Healthmark Industries for US$ 320 Million
This move strengthens Getinge’s position in the US sterile reprocessing market and aids Healthmark’s global expansion. Read More>>

Executive Movement
SHOWA Group appoints Charles Miller as President and COO of Americas and Oceania
Charles Miller will leverage his nearly two decades of experience with the company to drive growth, innovation, and product excellence. Read More>>

Partnerships
BridgeBio and Resilience announce Strategic Multi-Year Partnership
BridgeBio and National Resilience are partnering to manufacture and advance gene therapy treatments. Read More>>
Sai Life Sciences ties up with Dassault Systems to expedite drug discovery
The companies aim to expedite drug discovery by implementing the ONE Lab solution for enhanced productivity, data quality, security, and collaboration in R&D labs. Read More>>

Executive Movement
Alimera Sciences appoints Jason Werner as Chief Operating Officer
Jason brings extensive ophthalmic and commercial development experience to oversee global manufacturing and regulatory efforts, accelerating growth. Read More>>

Merger and Acquisition
Amgen completes US$27.8 Billion Horizon acquisition following FTC challenge
Amgen completes the acquisition of Horizon Therapeutics after overcoming FTC challenges regarding antitrust concerns and competition stifling. Read More>>

Product Launch
Moderna develops a Combination Vaccine for Influenza and COVID-19
Moderna unveils mRNA-1083, a combination vaccine targeting influenza and COVID-19. Phase 1/2 results show strong immune responses and a safety profile like the COVID-19 vaccine. Read More>>

• Allianz Life’s partnerships and digital initiatives provide customers with the convenience of accessing policy information, monitoring performance, and managing their accounts online.  
• Digital platforms enable Allianz Life to collect and analyze customer data, allowing for customized product offerings, more effective marketing, and increased customer satisfaction.

Annuity Product Enhancements

• Allianz Life’s enhancement of the Performance Lock feature empowers customers to make strategic decisions about their investments, potentially maximizing returns and protecting gains. 
• Allianz Life’s ability to adapt and enhance its annuity products in response to changing market conditions and customer demands demonstrates its agility and commitment to remaining relevant and competitive in the financial services industry.

Key Funding Alert

Shorla Oncology Raises $35 Million in Series B
This funding will support the growth of Shorla’s oncology portfolio, enabling the company to address drug shortages and enhance the application of oncology medication. Read More>>

Startup Spotlight

Company – Klarisana
Total Funding – USD 300 K
About: Klarisana is a leading mental health clinic specializing in ketamine infusion therapy and behavioral health services. Through personalized experiences, they aim to break the chains of mental suffering, fostering a renewed sense of purpose and psychological balance. Read More>>

Here’s what’s new on our Sales Intelligence Platform
Explore our new report view in Braindesk

• Discover ideal candidates with AI-powered Profile Recommendations in Projects, reducing your search time and effort.
• Dive into a refreshing report viewing experience with our revamped interface and user-friendly controls in Braindesk.